Skip to content
Forward Pharma logo — Pioneering new therapies in oncology and autoimmunity throug...

Forward Pharma

Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs.

Founded 2015 Series B Health Care, Pharmaceutical

General Information

Company Name Forward Pharma
Founded Year 2015
Industries Health Care, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Forward Pharma. To contact Forward Pharma, visit forward-pharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Forward Pharma compare?

A PDF of Forward Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Forward Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Forward Pharma

Forward Pharma, Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs. Established in 2015, the company is dedicated to Health Care and Pharmaceutical industries, focusing on developing innovative small-molecule pharmaceuticals and antibody-targeted drugs. Their primary focus is on discovering and advancing pioneering new treatments in the fields of oncology and autoimmunity. Forward Pharma recently received a Series B investment at 14 July 2023 from ZGC Group. This investment is a testament to the potential and promise that the company holds in revolutionizing therapies in these critical medical domains.

Business keywords: Oncology, Autoimmunity, Pharmaceuticals, Small-molecule drugs, Antibody-targeted drugs, Research and development, Innovation, Therapies, Medications

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 1
ZGC Group
14 Jul 2023

Forward Pharma Alternatives & Competitors

View All Alternatives
Forward Pharma vs
858 Therapeutics
858 Therapeutics United States

Discovering innovative small molecule therapeutics for the treatment of cancer

Venture round
30 employees
Biotechnology, Health Care
Forward Pharma vs

Committed to the fight against cancer and CNS disorders

136 employees
Biotechnology, Health Care
Forward Pharma vs

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...

Venture round
6 employees
Biotechnology, Health Care

FAQ About Forward Pharma

Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs.
Forward Pharma was founded in 2015.
Forward Pharma operates in Health Care and Pharmaceutical. Its work centres on Oncology, Autoimmunity, Pharmaceuticals and Small-molecule drugs.
Forward Pharma has completed 1 funding round. The latest funding stage is Series B.
Top alternatives and competitors to Forward Pharma include 858 Therapeutics, Astex Pharmaceuticals , Advenchen Laboratories, LLC, Anticancer Bioscience, ABM Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Forward Pharma and 858 Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Forward Pharma, https://bouncewatch.com/company/forward-pharma, updated 3 August 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout